Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07
Yoshihiro Kakeji, Kazuhiro Yoshida, Yasuhiro Kodera, Mitsugu Kochi, Takeshi Sano, Wataru Ichikawa, Sang‐Woong Lee, Kazushige SHIBAHARA, Toshio Shikano, Masato Kataoka, Atsushi Ishiguro, Hitoshi Ojima, Yoshinori Sakai, Nobuyuki Musha, Tsunenobu Takase, Taisei Kimura, Masahiro Takeuchi, Masashi Fujii
Topics & Concepts
DocetaxelMedicineInternal medicineHazard ratioCancerGastrectomyChemotherapyInterim analysisOncologyStage (stratigraphy)Randomized controlled trialSurgeryGastroenterologyConfidence intervalPaleontologyBiologyGastric Cancer Management and OutcomesCholangiocarcinoma and Gallbladder Cancer StudiesGastrointestinal Tumor Research and Treatment